Xsolis
AI utilization management, and the only vendor in this index positioned to sit between payer and provider rather than serving one side. The Dragonfly platform (formerly CORTEX) uses real time predictive analytics to continuously assign an objective medical necessity score, the proprietary Care Level Score, and an anticipated level of care for every patient, with the stated intent of removing subjectivity from patient status determination so both parties work from the same evidence. Product lines cover Utilize for utilization review and case management, Navigate for discharge readiness and length of stay, Advise for physician advisor workflow and peer to peer escalation, and revenue integrity for denials and appeals. Precision UM is the deepest tier, a shared utilization management approach between a health system and a health plan built on common clinical data and historical determination patterns. Integration with the EMR is bidirectional. The company also sells Physician Advisor Services, supplementing night and weekend coverage or operating fully outsourced, so buyers should separate the platform from the staffed service. Named outcome: AnMed reported 14.6x return on investment over a twelve month period and 1,221 hours of front end review time saved through Precision UM with a national health plan. A third party study found Dragonfly rendered clinical review determinations 38 percent faster than fax and 15 percent faster than through the EMR. Headquartered in Franklin, Tennessee; co-founded by Joan Butters.
Capability Axes
The Care Level Score is the product. Continuously scoring medical necessity and anticipated level of care for every patient in real time is a prediction task, and the platform's entire argument, that it removes subjectivity from status determination, only holds if a model rather than a reviewer is producing the score.
The oversight position is stated plainly and the design supports it: the company describes a human in the loop approach explicitly, and the platform produces a score and supporting evidence rather than a determination, leaving the medical necessity decision with clinical staff and physician advisors. That is the correct ceiling for a system whose output influences whether a patient is admitted or observed, and it contrasts with the several vendors in this index that claim autonomous determination without publishing a review step.
The only vendor in the utilization management cluster with peer reviewed research. Published studies across three US health systems evaluated level of care accuracy, observation discharge rates, and operational forecasting in live utilization management workflows. That is corroborated by a named health system result, AnMed reporting 14.6x return on investment over twelve months and 1,221 hours of front end review time saved, and by third party analysis finding determinations rendered 38 percent faster than fax and 15 percent faster than through the EMR. Graded on the existence and venue of peer reviewed evidence; this index does not re verify the underlying studies.
Bidirectional integration with the EMR is stated, with data flowing automatically in both directions to support real time scoring against live clinical documentation. Shared clinical access through Dragonfly between a health system and a national health plan is a genuinely unusual integration pattern, since it means both parties read the same record view. Held back from A because named EHR systems and certification detail were not retrieved.
No public pricing. Contact the vendor. Note the hybrid: alongside the platform the company sells Physician Advisor Services covering night and weekend gaps or operating fully outsourced, so the buy can be software, staffed service, or both. Establish which is being priced, since a clinical staffing component behaves very differently from a licence.
Precisely bounded to hospital utilization management and the workflows adjacent to it: admission and status determination, continued stay and concurrent authorization, discharge readiness and length of stay, physician advisor escalation, and denials and appeals. The position between payer and provider is stated as the design intent rather than a marketing frame, and Precision UM operationalizes it as a shared program.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Contact the vendor
|
Platform agreements with health systems and plans; separate physician advisory services | — | — | Vendor Published |
No rate card published. Two distinct things are sold and buyers should price them separately: the Dragonfly platform, and Physician Advisor Services in which the vendor's own physicians supplement night and weekend coverage or operate the function fully outsourced. A staffed clinical service carries a different cost structure and different scaling behaviour from software. Return on investment is framed at the program level, with one named health system reporting 14.6x over twelve months, so establish what is included in that denominator.